Quality of life (QOL) impact of adjuvant chemotherapy for early stage non- small cell lung cancer (NSCLC): Final analysis of JBR.10 randomized trial

被引：0
|
作者：
Bezjak, A.
Lee, C. W.
Ding, K.
Winton, T.
Brundage, M.
Graham, B.
Whitehead, M.
Seymour, L.
Shepherd, F. A.
机构：
[1] Princess Margaret Hosp, Toronto, ON, Canada
[2] BC Canc Agcy, Vancouver, BC, Canada
[3] NCIC CTG, Kingston, ON, Canada
[4] Univ Alberta Hosp, Edmonton, ON, Canada
[5] Kingston Reg Canc Ctr, Kingston, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7585
引用
收藏
页数：2
相关论文
共 50 条
  • [31] OUTCOMES OF PATIENTS UNDERGOING ADJUVANT PLATINUM- VINORELBINE CHEMOTHERAPY FOR RESECTED NON- SMALL CELL LUNG CANCER (NSCLC)
    Pender, Alexandra
    Coward, Jim
    Gunapala, Ranga
    Brien, Mary O.
    Bhosle, Jaishree
    Popat, Sanjay
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1168 - S1168
  • [32] Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
    Burdett, Sarah
    Pignon, Jean Pierre
    Tierney, Jayne
    Tribodet, Helene
    Stewart, Lesley
    Le Pechoux, Cecile
    Auperin, Anne
    Le Chevalier, Thierry
    Stephens, Richard J.
    Arriagada, Rodrigo
    Higgins, Julian P. T.
    Johnson, David H.
    Van Meerbeeck, Jan
    Parmar, Mahesh K. B.
    Souhami, Robert L.
    Bergman, Bengt
    Douillard, Jean-Yves
    Dunant, Ariane
    Endo, Chiaki
    Girling, David
    Kato, Harubumi
    Keller, Steven M.
    Kimura, Hideki
    Knuuttila, Aija
    Kodama, Ken
    Komaki, Ritsuko
    Kris, Mark G.
    Lad, Thomas
    Mineo, Tommaso
    Piantadosi, Steven
    Rosell, Rafael
    Scagliotti, Giorgio
    Seymour, Lesley K.
    Shepherd, Frances A.
    Sylvester, Richard
    Tada, Hirohito
    Tanaka, Fumihiro
    Torri, Valter
    Waller, David
    Liang, Ying
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (03):
  • [33] Neo-adjuvant chemotherapy in early stage non-small cell lung cancer
    Boukovinas, Ioannis
    Tsakiridis, Kosmas
    Zarogoulidis, Paul
    Machairiotis, Nikolaos
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Zarogoulidis, Kostantinos
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S446 - S448
  • [34] Adjuvant Chemotherapy in Patients With Early-Stage Non-Small Cell Lung Cancer
    Inamura, Kentaro
    JAMA ONCOLOGY, 2021, 7 (04) : 637 - 638
  • [35] P53 protein over-expression but not p53 gene mutation is a poor prognostic marker and a predictive marker for survival benefit from adjuvant chemotherapy in non-small cell lung cancer (NSCLC) in the JBR.10 Trial
    Tsao, M. S.
    Aviel-Ronen, S.
    Ding, K.
    Lau, D.
    Liu, N.
    Whitehead, M.
    Seymour, L.
    Winton, T.
    Shepherd, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Highlights in management of early stage non- small cell lung cancer
    Li, Grace
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (04) : 311 - +
  • [37] A Cost-Effectiveness Analysis of Using the JBR.10-Based 15-Gene Expression Signature to Guide Adjuvant Chemotherapy in Early Stage Non-Small-Cell Lung Cancer
    Wong, Kit Man
    Ding, Keyue
    Li, Suzanne
    Bradbury, Penelope
    Tsao, Ming-Sound
    Der, Sandy D.
    Shepherd, Frances A.
    Chung, Carmen
    Ng, Raymond
    Seymour, Lesley
    Leighl, Natasha B.
    CLINICAL LUNG CANCER, 2017, 18 (01) : E41 - E47
  • [38] Quality of life during chemotherapy (MIC) in non-small-cell-lung-cancer (NSCLC)
    Sirgo, A
    Diaz-Ovejero, MB
    García-Gómez, R
    Guevara-Méndez, S
    López-Criado, P
    López-López, C
    Alija-López, V
    Pérez-Manga, G
    PSYCHO-ONCOLOGY, 1999, 8 (06) : 62 - 62
  • [39] Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC)
    Lee, SW
    Choi, EK
    Chung, WK
    Shin, KH
    Ahn, SD
    Kim, JH
    Kim, SW
    Suh, C
    Lee, JS
    Kim, WS
    Kim, DS
    Kim, DK
    Park, SI
    Sohn, KH
    LUNG CANCER, 2002, 37 (01) : 65 - 71
  • [40] The impact of adjuvant vinorelbine (VIN) and cisplatin (CIS) on quality of life (QoL): Results from The National Cancer Institute of Canada Clinical Trials Group Trial BR.10 randomized trial of VIN/CIS versus observation in stage IB and II non-small cell lung cancer (NSCLC)
    Shepherd, F.
    Winton, T.
    Livingston, R.
    Johnson, D.
    Rigas, J.
    Cormier, Y.
    Bezjak, A.
    Ding, K.
    Graham, B.
    Seymour, L.
    ANNALS OF ONCOLOGY, 2004, 15 : 165 - 166
12345